Belotendos, Sheenly S.

HRN: 11-59-12  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2026
CEFTRIAXONE 1G (VIAL)
05/07/2026
05/14/2026
IV
1g
Q12
T/c Acute Appendicitis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueProphylaxis    Compliance to guidelines: Compliant To Guidelines